[Treatment of haemorrhage with transfusion preparations and blood derivatives].
Appropriate use of blood components and blood products improved both patients care and use of health care resources. In bleeding and/or risk bleeding situations use of these products is often indicated. The authors summarise different guidelines, experiences, indications and problems in hemotherapy concerning bleeding complications.
Buliková
A
A
Oddĕlení klinické hematologie FN Brno. abulik@fnbrno.cz
Matýsková
M
M
Penka
M
M
D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D016913:Blood Component Transfusion; D001802:Blood Substitutes; D001803:Blood Transfusion; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy*; D006801:Humans
D001779:Blood Coagulation Factors; D001802:Blood Substitutes